Castle Biosciences, Inc. (CSTL)

Castle Biosciences Revenue

In the year 2023, Castle Biosciences had annual revenue of $219.79M with 60.38% growth. Revenue in the quarter ending December 31, 2023 was $66.12M with 72.47% year-over-year growth.

• Revenue (ttm): $219.79M
• Revenue Growth: +60.38%
• P/S Ratio: 2.75
• Revenue / Employee: $360,308
• Employees: 610
• Market Cap: 604.45M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	219.79M	82.75M	60.38%
Dec 31, 2022	137.04M	42.95M	45.65%
Dec 31, 2021	94.09M	31.44M	50.18%
Dec 31, 2020	62.65M	10.78M	20.79%
Dec 31, 2019	51.87M	29.08M	127.62%
Dec 31, 2018	22.79M	9.03M	65.67%
Dec 31, 2017	13.75M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.